Visit COVID-19 resources

[Skip to Content]

Eye Journal

Initial treatment of macular oedema due to central retinal vein occlusion—which anti-VEGF agent to choose? – (Eye Journal)

Nov 26
2019

Eye, Published online: 26 November 2019; doi:10.1038/s41433-019-0706-6 Initial treatment of macular oedema due to central retinal vein occlusion—which anti-VEGF agent to choose?

  • 26 November 2019

Endoscopic dacryocystorhinostomy with and without mucosal flap—is there any difference? – (Eye Journal)

Nov 25
2019

Eye, Published online: 25 November 2019; doi:10.1038/s41433-019-0716-4 Endoscopic dacryocystorhinostomy with and without mucosal flap—is there any difference?

  • 25 November 2019

Management of patients with macular oedema secondary to central retinal vein occlusion: new findings from SCORE2 and LEAVO studies – (Eye Journal)

Nov 25
2019

Eye, Published online: 25 November 2019; doi:10.1038/s41433-019-0708-4 Management of patients with macular oedema secondary to central retinal vein occlusion: new findings from SCORE2 and LEAVO studies

  • 25 November 2019

Risk of acute stroke in patients with retinal artery occlusion – (Eye Journal)

Nov 25
2019

Eye, Published online: 25 November 2019; doi:10.1038/s41433-019-0715-5 Risk of acute stroke in patients with retinal artery occlusion

  • 25 November 2019

Response to ‘Comment on: ‘A new era for giant cell arteritis’’ – (Eye Journal)

Nov 25
2019

Eye, Published online: 25 November 2019; doi:10.1038/s41433-019-0703-9 Response to ‘Comment on: ‘A new era for giant cell arteritis’’

  • 25 November 2019